Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
9.52
+0.30 (3.31%)
Nov 24, 2025, 4:00 PM EST - Market closed
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$37,800
Profits / Employee
-$1,235,171
Market Cap
58.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70 | 4 | 6.06% |
| Dec 31, 2023 | 66 | -17 | -20.48% |
| Dec 31, 2022 | 83 | -10 | -10.75% |
| Dec 31, 2021 | 93 | 19 | 25.68% |
| Dec 31, 2020 | 74 | 13 | 21.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALGS News
- 4 days ago - Aligos Therapeutics, Inc. (ALGS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 10 days ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 - GlobeNewsWire
- 18 days ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - GlobeNewsWire
- 20 days ago - Aligos Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference - GlobeNewsWire